Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion
HC Diener(University of Duisburg-Essen), Emmanuel Touzé(Centre Hospitalier Universitaire de Caen), Antoni Dávalos(Hospital Universitari Germans Trias i Pujol), Stephen M. Davis(The Royal Melbourne Hospital), Derk Krieger(Department of Health and Social Care), José M. Ferro(University of Lisbon), Agnieszka Słowik(Jagiellonian University), Bruce Campbell(The Royal Melbourne Hospital), George Ntaios(Çevre, Şehircilik ve İklim Değişikliği Bakanlığı), Kenneth Butcher(University of Alberta), Richard A. Bernstein(Northwestern University), Martin Grond(Boehringer Ingelheim (Germany)), Geoffrey Cloud(Monash University)
Cited by 69
Related Papers
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k
Cryptogenic Stroke and Underlying Atrial Fibrillation
|New England Journal of Medicine|2014|2.2k
Ischaemic stroke
|Nature Reviews Disease Primers|2019|1.7k
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
|New England Journal of Medicine|2017|1.1k